St. Joseph’s Companion Aspirin
This article was originally published in The Tan Sheet
Executive Summary
McNeil Consumer & Specialty Pharmaceuticals introduces specially packaged St. Joseph's aspirin for consumers to take in the event of a suspected heart attack, the firm announces Aug. 23. Companion Aspirin, which began shipping in July, includes three individual packets, each containing two chewable tablets of aspirin 81 mg. Each individual packet provides the "emergency" dose recommended at onset of heart attack symptoms in an easy-to-open pouch and will retail for $1.00, McNeil notes. FDA approved modified labeling for aspirin in 1998, allowing language recommending aspirin use during suspected acute myocardial infarction (1"The Tan Sheet" Oct. 26, 1998, p. 4)...
You may also be interested in...
Aspirin Professional Indications Add Use During Acute MI In FDA Final Rule
FDA's final rule on professional labeling for aspirin includes an indication for aspirin use during suspected acute myocardial infarction as soon as a heart attack is suspected, as directed by health care personnel.
US FDA Expects Joint AdComm Briefing Document, Oncology Chief Says
The combined format is the new default for briefing advisory committee members, US FDA Oncology Center of Excellence Director Pazdur declared.
Parallel Scientific Advice: Is The EMA User Fee Impacting Interest?
EMA charges participants to receive scientific advice through the fledgling program, unlike the US FDA, which may not fit the budgets of some complex generic sponsors. At the same time, sponsors also may simply not be aware the program exists yet.